| Cisplatin-Induced Ototoxicity: A concise review of the burden, prevention, and interception strategies A Chattaraj, MP Syed, CA Low, TK Owonikoko JCO Oncology Practice 19 (5), 278-283, 2023 | 23 | 2023 |
| Pneumocystis jiroveci pneumonia: a review of management in human immunodeficiency virus (HIV) and non-HIV immunocompromised patients A Ibrahim, A Chattaraj, Q Iqbal, A Anjum, MEU Rehman, Z Aijaz, F Nasir, ... Avicenna Journal of Medicine 13 (01), 023-034, 2023 | 18 | 2023 |
| Efficacy and safety of regimens used for the treatment of multicentric Castleman disease: a systematic review MEU Rehman, A Chattaraj, K Neupane, A Rafae, S Saeed, J Basit, ... European Journal of Haematology 109 (4), 309-320, 2022 | 9 | 2022 |
| Emerging targets and cellular therapy for relapsed refractory multiple myeloma: a systematic review LL George, SR Deshpande, MJ Cortese, EK Kendall, A Chattaraj, Z Shah, ... Clinical Lymphoma Myeloma and Leukemia 21 (11), 741-751, 2021 | 8 | 2021 |
| Total body irradiation versus chemotherapy conditioning in pediatric acute lymphoblastic leukemia patients undergoing hematopoietic stem cell transplant: a systematic review … MEU Rehman, A Chattaraj, A Mahboob, Z Ijaz, D Franco, M Farhan, ... Clinical Lymphoma Myeloma and Leukemia 23 (4), 249-258, 2023 | 6 | 2023 |
| Novel Pharmacological Treatment Options of Steroid‐Refractory Graft‐versus‐Host Disease I Kovalenko, T Saleem, M Shah, S Seyedroudbari, K Golubykh, R Ali, ... Advances in Hematology 2023 (1), 9949961, 2023 | 5 | 2023 |
| Safety and efficacy of allogeneic CAR-T cells in B-cell malignancies: A systematic review and meta-analysis. A Chattaraj, MEU Rehman, I Khan, D Franco, A Ibrahim, R Khanam, ... Journal of Clinical Oncology 40 (16_suppl), e19530-e19530, 2022 | 4 | 2022 |
| T-cell redirected bispecific antibodies in relapsed and refractory multiple myeloma: A systematic review and meta-analysis. SHB Waqar, R Khanam, MEU Rehman, A Chattaraj, H Ali, F Anwer Journal of Clinical Oncology 40 (16_suppl), e20014-e20014, 2022 | 1 | 2022 |
| 313: BELL PALSY: IT CAN BE COVID-19! W Ali, T Ahmad, K Ahmad, A Chattaraj, A Pillai Critical Care Medicine 50 (1), 143, 2022 | 1 | 2022 |
| Novel Drugs in the Treatment of Steroid Refractory Acute Graft Versus Host Disease I Kovalenko, T Saleem, B Laek, R Ali, T Mirza, A Chattaraj, A Wahab, ... Blood 140 (Supplement 1), 12895-12896, 2022 | | 2022 |
| Tyrosine Kinase Inhibitors in the Treatment of Steroid Refractory Chronic Graft Versus Host Disease T Saleem, I Kovalenko, B Laek, R Ali, TM Mirza, A Chattaraj, A Wahab, ... Blood 140 (Supplement 1), 12898-12899, 2022 | | 2022 |
| Outcomes after venetoclax with hypomethylating agents in myelodysplastic syndromes: a systematic review and meta-analysis R Khanam, M Shahzad, SG Chaudhary, F Ali, Z Shah, PS Pachika, ... Leukemia & Lymphoma, 1-8, 2022 | | 2022 |
| Total body irradiation versus chemotherapy conditioning in pediatric acute lymphoblastic leukemia patients undergoing hematopoietic stem cell transplant: A systematic review … MEU Rehman, A Chattaraj, A Mahboob, Z Ijaz, D Franco, MM Aslam, ... Journal of Clinical Oncology 40 (16_suppl), e22002-e22002, 2022 | | 2022 |
| Ruxolitinib in chronic steroid-refractory graft-versus-host-disease. I Kovalenko, T Saleem, B Laek, R Ali, TM Mirza, A Chattaraj, A Wahab, ... Journal of Clinical Oncology 40 (16_suppl), e19053-e19053, 2022 | | 2022 |
| Does acute cholangitis impact outcomes of cholangiocarcinoma? Insights from a nationwide database. R Lee, D Franco, U Farooq, A Chattaraj, MEU Rehman, F Anwer Journal of Clinical Oncology 40 (16_suppl), e16138-e16138, 2022 | | 2022 |
| Mucormycosis in hematopoetic stem cell transplant recipients: A systematic review. MEU Rehman, S Saeed, D Franco, A Chattaraj, J Basit, H Khan, F Fazal, ... Journal of Clinical Oncology 40 (16_suppl), e19043-e19043, 2022 | | 2022 |
| Beyond gemtuzumab ozogamicin: A systematic review of antibody therapies for acute myeloid leukemia. V Sumbly, I Landry, Q Iqbal, MEU Rehman, A Chattaraj, Z Aijaz, ... Journal of Clinical Oncology 40 (16_suppl), e19006-e19006, 2022 | | 2022 |
| The association between minimal residual disease status and survival outcomes in transplant-ineligible newly diagnosed multiple myeloma (TIE-NDMM) patients: Systematic review. Z Shah, I Khan, II Selene, SHB Waqar, R Khanam, Q Abid, N Tahir, ... Journal of Clinical Oncology 40 (16_suppl), e20009-e20009, 2022 | | 2022 |
| A CASE OF MYASTHENIC CRISIS FOLLOWING COVID-19 VACCINE A Chattaraj, J Sallit, J Arnold SHM Converge 2022, 2022 | | 2022 |
| 418: A TALE OF TWO ARTERIES: A CASE OF NSTEMI DUE TO CORONARY ARTERY COMPRESSION BY PULMONARY ARTERY T Ahmad, W Ali, K Ahmad, A Chattaraj, A Pillai Critical Care Medicine 50 (1), 198, 2022 | | 2022 |
